๊ธˆ์œต
ํ™ˆYPH โ€ข FRA
์•„์Šคํ…”๋ผ์Šค ์ œ์•ฝ
โ‚ฌ8.95
2์›” 12์ผ, ์˜คํ›„ 10์‹œ 59๋ถ„ 36์ดˆ GMT+1 · EUR · FRA · ๋ฉด์ฑ…์กฐํ•ญ
์ฃผ์‹DE ์ƒ์žฅ ์ฆ๊ถŒJP์— ๋ณธ์‚ฌ ์†Œ์žฌ
์ „์ผ ์ข…๊ฐ€
โ‚ฌ9.02
์ผ์ผ ๋ณ€๋™ํญ
โ‚ฌ8.79 - โ‚ฌ8.95
52์ฃผ ๋ณ€๋™ํญ
โ‚ฌ8.47 - โ‚ฌ11.70
์‹œ๊ฐ€์ด์•ก
2.62์กฐ JPY
ํ‰๊ท  ๊ฑฐ๋ž˜๋Ÿ‰
120.00
์ฃผ๊ฐ€์ˆ˜์ต๋ฅ 
-
๋ฐฐ๋‹น์ˆ˜์ต๋ฅ 
-
๊ธฐ๋ณธ ๊ฑฐ๋ž˜์†Œ
TYO
๋‰ด์Šค
MarketBeat
13์‹œ๊ฐ„ ์ „
Astellas Pharma (OTCMKTS:ALPMY) Stock Price Crosses Below 50 Day Moving Average - Here's Why
4503
0.31%
ALPMY
1.89%
Financial Times
17์‹œ๊ฐ„ ์ „
Activist fund takes aim at one of Japanโ€™s biggest pharma groups
4503
0.31%
FiercePharma
4์‹œ๊ฐ„ ์ „
Astellas shifts investment focus to later-stage opportunities amid reprioritization
4503
0.31%
Investing.com UK
2์ผ ์ „
Pfizer and Astellas report improved survival in bladder cancer trial By Investing.com
PFE
0.24%
4503
0.31%
์žฌ๋ฌด
์†์ต๊ณ„์‚ฐ์„œ
์ˆ˜์ต
์ˆœ์ด์ต
(JPY)2024๋…„ 12์›”์ „๋…„๋Œ€๋น„ ๋ณ€๋™
์ˆ˜์ต
5174.08์–ต22.63%
์šด์˜๋น„
3439.91์–ต5.14%
์ˆœ์ด์ต
-976.60์–ต-772.91%
์ˆœ์ด์ต๋ฅ 
-18.87-648.55%
์ฃผ๋‹น ์ˆ˜์ต
โ€”โ€”
EBITDA
1260.58์–ต91.43%
์œ ํšจ ์„ธ์œจ
17.49%โ€”
์ด์ž์‚ฐ
์ด๋ถ€์ฑ„
(JPY)2024๋…„ 12์›”์ „๋…„๋Œ€๋น„ ๋ณ€๋™
ํ˜„๊ธˆ ๋ฐ ๋‹จ๊ธฐ ํˆฌ์ž
1798.65์–ต-29.18%
์ด์ž์‚ฐ
3.45์กฐ2.46%
์ด๋ถ€์ฑ„
1.96์กฐ4.95%
์ด์ž๊ธฐ์ž๋ณธ
1.49์กฐโ€”
๋ฐœํ–‰ ์ฃผ์‹
17.90์–ตโ€”
์ฃผ๊ฐ€์ˆœ์ž์‚ฐ๋น„์œจ
0.01โ€”
์ด์ž์‚ฐ์ด์ต๋ฅ 
5.42%โ€”
์ž๋ณธ์ด์ต๋ฅ 
7.69%โ€”
์ˆœํ˜„๊ธˆํ๋ฆ„
(JPY)2024๋…„ 12์›”์ „๋…„๋Œ€๋น„ ๋ณ€๋™
์ˆœ์ด์ต
-976.60์–ต-772.91%
์˜์—… ํ˜„๊ธˆ ํ๋ฆ„
160.26์–ต-68.83%
ํˆฌ์ž ํ˜„๊ธˆ ํ๋ฆ„
-307.22์–ต23.79%
์ž๊ธˆ ์กฐ๋‹ฌ ํ˜„๊ธˆ ํ๋ฆ„
-1042.96์–ต-19.85%
์ˆœํ˜„๊ธˆํ๋ฆ„
-1131.27์–ต-41.38%
์ž‰์—ฌ ํ˜„๊ธˆ ํ๋ฆ„
138.28์–ต-53.18%
์ •๋ณด
์•„์Šคํ…”๋ผ์Šค ์ œ์•ฝ ์ฃผ์‹ํšŒ์‚ฌ๋Š” ์ผ๋ณธ์˜ ์ œ์•ฝ ํšŒ์‚ฌ์ด๋‹ค. Wikipedia
CEO
์„ค๋ฆฝ
2005. 4. 1.
๋ณธ์‚ฌ
๋„์ฟ„๋„ ์ฃผ์˜ค๊ตฌ
์ผ๋ณธ
์›น์‚ฌ์ดํŠธ
astellas.com
์ง์› ์ˆ˜
14,754
๋” ์•Œ์•„๋ณด๊ธฐ
๊ด€์‹ฌ ์žˆ์„ ๋งŒํ•œ ์ฃผ์‹ ์ •๋ณด
์ด ๋ชฉ๋ก์€ ์ตœ๊ทผ ๊ฒ€์ƒ‰์–ด, ํŒ”๋กœ์šฐํ•œ ์ฆ๊ถŒ, ๊ธฐํƒ€ ํ™œ๋™์„ ๊ธฐ๋ฐ˜์œผ๋กœ ์ƒ์„ฑ๋˜์—ˆ์Šต๋‹ˆ๋‹ค. ์ž์„ธํžˆ ์•Œ์•„๋ณด๊ธฐ

๋ชจ๋“  ๋ฐ์ดํ„ฐ์™€ ์ •๋ณด๋Š” ๊ฐœ์ธ์—๊ฒŒ ์ •๋ณด๋ฅผ ์ œ๊ณตํ•˜๋Š” ๋ชฉ์ ์œผ๋กœ '์žˆ๋Š” ๊ทธ๋Œ€๋กœ' ์ œ๊ณต๋˜๋ฉฐ ๊ธˆ์œต ์ž๋ฌธ์ด๋‚˜ ๊ฑฐ๋ž˜ ๋˜๋Š” ํˆฌ์ž, ์„ธ๊ธˆ, ๋ฒ•๋ฅ , ํšŒ๊ณ„ ๋“ฑ์— ๊ด€ํ•œ ์ž๋ฌธ์„ ์˜๋„ํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค. Google์€ ํˆฌ์ž ์ž๋ฌธ๊ฐ€๊ฐ€ ์•„๋‹ˆ๋ฉฐ ์ด ๋ชฉ๋ก์— ํฌํ•จ๋œ ํšŒ์‚ฌ ๋˜๋Š” ์ด๋Ÿฌํ•œ ํšŒ์‚ฌ์—์„œ ๋ฐœํ–‰ํ•œ ์ฆ๊ถŒ๊ณผ ๊ด€๋ จํ•˜์—ฌ ๊ฒฌํ•ด, ์ถ”์ฒœ ์˜์‚ฌ ๋˜๋Š” ์˜๊ฒฌ์„ ๋ฐํžˆ์ง€ ์•Š์Šต๋‹ˆ๋‹ค. ๊ฑฐ๋ž˜๋ฅผ ์ฒด๊ฒฐํ•˜๊ธฐ ์ „์— ์ค‘๊ฐœ์ธ์ด๋‚˜ ๊ธˆ์œต ๋Œ€๋ฆฌ์ธ์—๊ฒŒ ๋ฌธ์˜ํ•˜์—ฌ ๊ฐ€๊ฒฉ์„ ํ™•์ธํ•˜์„ธ์š”. ์ž์„ธํžˆ ์•Œ์•„๋ณด๊ธฐ
ํ•จ๊ป˜ ๊ฒ€์ƒ‰ํ•œ ํ•ญ๋ชฉ
OGN
Organon & Co
$14.70
1.71%
๊ฒ€์ƒ‰
๊ฒ€์ƒ‰์–ด ์ง€์šฐ๊ธฐ
๊ฒ€์ƒ‰ ๋‹ซ๊ธฐ
Google ์•ฑ
๊ธฐ๋ณธ ๋ฉ”๋‰ด